Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
02/2000
02/16/2000CN1049431C Morpholine derivative and its use and medicinal prepration containing said derivatives
02/15/2000US6025494 Tetracyclic derivatives, process of preparation and use
02/15/2000US6025398 Benzamidoxime prodrugs as antipneumocystic agents
02/15/2000US6025376 Chiral methylphenyloxazolidinones
02/15/2000US6025361 Effective pde iv inhibitors, asthma
02/15/2000US6025360 Use of theophylline for the manufacture of a medicament for the treatment of asthma
02/15/2000US6025354 Exhibit phosphodiesterase iv inhibition and can be used to treat asthmatic disorders.
02/15/2000US6025339 Oligo is antisense to the initiation codon, the coding region or the 5' and 3' intronexon junctions of a gene encoding the adenosine a.sub.1 receptor or antisense to an adenosine a.sub.1 receptor mrna; and
02/15/2000US6025166 Human trk receptors and neurotrophic factor inhibitors
02/15/2000CA2197739C 1,4-dihydropyridine compounds
02/10/2000WO2000006768A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
02/10/2000WO2000006767A1 Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases
02/10/2000WO2000006743A2 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000WO2000006738A2 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
02/10/2000WO2000006730A2 Human cytoskeletal proteins
02/10/2000WO2000006709A1 Human protein kinase h2lau20
02/10/2000WO2000006698A1 98 human secreted proteins
02/10/2000WO2000006694A2 Compound and method for the prevention and/or the treatment of allergy
02/10/2000WO2000006589A1 Prostate derived ets factor
02/10/2000WO2000006588A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
02/10/2000WO2000006580A1 Pyridobenzothiazine derivatives and process for producing the same
02/10/2000WO2000006578A1 Pyridobenzoxazine derivatives and process for producing the same
02/10/2000WO2000006572A1 Bensoquinolizine derivatives and process for producing the same
02/10/2000WO2000006571A1 Pyrroloquinoline derivatives and process for producing the same
02/10/2000WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity
02/10/2000WO2000006545A1 High affinity ligands for nociceptin receptor orl-1
02/10/2000WO2000006544A1 Cyclic amine derivatives and process for the preparation thereof
02/10/2000WO2000006531A2 Nitric esters and nitrate salts of specific drugs
02/10/2000WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
02/10/2000WO2000006153A1 Propenamides as ccr5 modulators
02/10/2000WO2000006146A1 Substituted anilide compounds and methods
02/10/2000WO2000006121A1 Medicinal aerosol formulations
02/10/2000WO2000006085A2 Compounds and methods
02/10/2000WO2000000510A8 Growth factor modulators
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999061012A3 Therapeutic dinucleotide and derivatives
02/10/2000WO1999049039A3 GFRα3 AND ITS USES
02/10/2000DE19835325A1 Verwendung von Cyclopentabenzofuran-Derivaten zur Bekämpfung von NF-kB abhängigen Krankheiten Use of cyclopentabenzofuran derivatives for the control of NF-kB-dependent diseases
02/10/2000DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use
02/10/2000CA2339301A1 Hdpbo81 nucleic acids and polypeptides
02/10/2000CA2338804A1 Propenamides as ccr5 modulators
02/10/2000CA2338764A1 Substituted anilide compounds and methods
02/10/2000CA2338697A1 Compounds and methods
02/10/2000CA2338019A1 Prostate derived ets factor
02/10/2000CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2335656A1 Human cytoskeletal proteins
02/10/2000CA2333854A1 Stereoisomers of cpg oligonucleotides and related methods
02/09/2000EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments
02/09/2000EP0977850A1 Edg-1-like receptor
02/09/2000EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
02/09/2000EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
02/09/2000EP0977725A1 New fatty acid derivatives
02/09/2000EP0977590A1 Human monoclonal antibodies
02/09/2000EP0977577A1 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
02/09/2000EP0977569A1 Pharmaceutical composition for supressing type 2 helper t cell immune response
02/09/2000EP0977568A1 Benzocycloheptathiophene compounds
02/09/2000EP0977565A1 Pharmaceutical composition
02/09/2000EP0977554A1 Confectionery compositions
02/09/2000EP0977553A1 Throat soothing compositions
02/09/2000CN1244120A New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 G/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof
02/09/2000CN1243827A Preparation of heterocyclic amide derivative with specific physical status
02/09/2000CN1243749A Inhibitor
02/09/2000CN1243732A Chinese medicine 'Baoeryin' and its preparing process
02/09/2000CN1243717A Medicine for curing common cold and cough and its preparing process
02/08/2000US6022978 Benzimidazole derivatives
02/08/2000US6022971 Azetidines
02/08/2000US6022969 Symmetrical bis(aminoalkyl), bis(amidinoalkyl) and bis(guanidinoalkyl) cycloalkanes
02/08/2000US6022884 Substituted pyridine compounds and methods of use
02/08/2000US6022864 Nucleic acid respiratory syncytial virus vaccines
02/08/2000US6022694 Assay for ligands to tyrosine kinase receptors
02/08/2000US6022527 Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof
02/08/2000CA2006387C Xanthine derivatives with adenosine-antagonistic activity
02/03/2000WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1)
02/03/2000WO2000005269A1 Polymer complexes of glucuronoglucanes
02/03/2000WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb
02/03/2000WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor
02/03/2000WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors
02/03/2000WO2000005219A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
02/03/2000WO2000005218A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
02/03/2000WO2000005216A1 Il-8 receptor antagonists
02/03/2000WO2000005207A1 Substituted phenylamidines with antithrombotic action
02/03/2000WO2000004939A1 Dental pin
02/03/2000WO2000004937A1 Flat flexible materials
02/03/2000WO2000004929A1 Use of decreasing levels of functional transient receptor potential gene product
02/03/2000WO2000004925A1 Slow release formulations comprising anionic polysaccharide
02/03/2000WO2000004923A1 Scrp-5: secreted cysteine rich protein-5
02/03/2000WO2000004907A1 An antilipemic formulation
02/03/2000WO2000004891A2 Anti-ulcer composition
02/03/2000WO2000004882A1 Formulations of anionic polysaccharides
02/03/2000WO2000004877A1 Suppository formulations comprising anionic polysaccharide
02/03/2000WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
02/03/2000WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors
02/03/2000WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors
02/03/2000WO1999058504A9 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament
02/03/2000DE19834714A1 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 2,3,3a, 4,9,9a-hexahydro-8-hydroxy-1H-ben [f] indoles, to processes for their preparation and their use as medicaments
02/03/2000DE19834713A1 Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New phenylethylamine derivatives, processes for their preparation and their use as medicaments
02/03/2000CA2338741A1 Il-8 receptor antagonists
02/03/2000CA2338299A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
02/03/2000CA2338044A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
02/03/2000CA2337954A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
1 ... 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 ... 878